Can a filler fix 'Ozempic Face'? new trial aims to find out

NCT ID NCT07221461

Not yet recruiting Symptom relief Sponsor: Goldman, Butterwick, Fitzpatrick and Groff Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 2 trial tests whether injecting a hyaluronic acid filler (Skinvive) into the cheeks can improve skin quality in people taking GLP-1 weight loss medications. 24 women aged 25-50 will participate: 16 on GLP-1 drugs and 8 not on them. Researchers will measure changes in fine lines, pigmentation, firmness, and radiance over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: hyaluronic acid filler (Skinvive)
What this could lead to: If it works, this could offer a cosmetic option to improve skin quality for people experiencing skin changes from GLP-1 weight loss therapy.
What could go wrong: This is a small, early-phase study with only 24 participants, so results may not apply broadly. The filler is for cosmetic improvement only and does not treat any underlying disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for WRINKLE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cutis laxa

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

WRINKLE

Contacts and locations

Locations

West Dermatology Research Center

San Diego, California, 92121, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.